Financial Year |
March 31 2023 |
Monetary Funds |
331,211,010.68 |
Held-for-trading Financial Assets |
200,774,654.17 |
Notes Receivable |
55,526,088.84 |
Accounts Receivable |
58,604,881.10 |
Advances to Suppliers |
798,888.61 |
Other Receivables |
186,535.00 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
115,783,960.93 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
-- |
Total Current Assets |
763,474,553.04 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
68,534,152.67 |
Under-construction Projects |
2,283,966.39 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
41,426,482.59 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
15,238,542.70 |
Other Non-Current Assets |
23,364,657.33 |
Sub-Total of Non-Current Assets |
152,405,122.33 |
Total Assets |
915,879,675.37 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
7,222,608.00 |
Accounts Payable |
21,376,311.14 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
9,650,879.75 |
Taxes Payable |
2,484,324.42 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
3,236,743.11 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,067,696.92 |
Other Current Liabilities |
5,293,919.38 |
Sub-Total of Current Liabilities |
53,641,078.08 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
427,177.58 |
Other Non-Current Liabilities |
6,424,945.61 |
Sub-Total of Non-Current Liabilities |
7,963,668.48 |
Total Liabilities |
61,604,746.56 |
Paid-In Capital(Or Share Stock) |
320,000,000.00 |
Capital Surplus |
192,698,060.65 |
Surplus Reserve |
36,645,443.86 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
304,157,170.23 |
Minority Stockholder's Interest |
774,254.07 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
853,500,674.74 |
Owner's Equity(Stockholder's Equity) |
854,274,928.81 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
915,879,675.37 |